Hanmi presents solution package strategy to potentially overcome COVID 19 at the 39th JP Morgan Healthcare Conference

Hanmi presents solution package strategy to potentially overcome COVID-19 at the 39th JP Morgan Healthcare Conference

Condividi: 13 gennaio 2021 Hanmi Pharmaceutical Co., Ltd. develops a full package strategy to potentially handle the COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine)
Recently releases Hanmi Cold-Mask™(nasal spray) and on preparation to release COVID-19 & Influenza dual diagnostic kit
SEOUL, South Korea, Jan. 12, 2021 /PRNewswire/ — Hanmi Pharmaceutical Co., Ltd., announced “endless challenges and new commitments for the pharmaceutical industry” leggi di più…